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Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) has become one of the most
widespread causes of nosocomial infections worldwide. Recently, reports have emerged that S.
aureus strains recovered from community-acquired infections are also methicillin-resistant. This
study was undertaken to analyze the prevalence of methicillin resistance among isolates at a
regional hospital in Trinidad, and document the current resistance profile of MRSA and methicillin-
sensitive Staphylococcus aureus (MSSA) to the commonly used anti-staphylococcal agents.
Methods: Over a 6-year period we analyzed 2430 isolates of S. aureus strains recovered from
various clinical sources, from hospital and community practices. Antimicrobial susceptibility testing
was done according to guideline recommendations of the National Committee for Clinical
Laboratory Standards.
Results: The prevalence of MRSA from surgical/burn wounds, urine and pus/abscess were 60.1%,
15.5% and 6.6%, respectively. The major sources of MSSA were surgical/burn wounds, pus/abscess
and upper respiratory tract specimens with rates of 32.9%, 17.1% and 14.3%, respectively. The
greatest prevalence of resistance of MRSA was seen for erythromycin (86.7%), and clindamycin
(75.3%). Resistance rates among MSSA were highest for ampicillin (70%). Resistance rates for
tetracycline were similar among both MRSA (78.7%) and MSSA (73.5%). The MRSA recovery rates
from nosocomial sources (20.8%) was significantly higher than that of previous years (12.5%) (p <
0.001), whereas rates among community isolates were relatively similar for the same period (4.1%
versus 8.1%).
Conclusion: The prevalence of MRSA in the hospital increased from 12.5% in 1999 to 20.8% in
2004. Most isolates were associated with infected surgical/burn wounds which may have become
infected via the hands of HCPs during dressing exercises. Infection control measures aimed at the
proper hand hygiene procedures may interrupt the spread of MRSA. HCPs may also be carriers of
MRSA in their anterior nares. Surveillance cultures of both patients and HCPs may help to identify
carriers who would be offered antibiotics to eradicate the organisms. Most MRSA are resistant to
several non-β-lactam antibiotics. Frequent monitoring of susceptibility patterns of MRSA and the
formulation of a definite antibiotic policy maybe helpful in decreasing the incidence of MRSA
infection.
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Background
Staphylococcus aureus remains one of the most frequently
isolated pathogens in both community and hospital prac-
tices. The organism has been found to be the most com-
mon bacterial agent recovered from blood stream
infections, skin and soft tissue infections, pneumonia and
hospital-acquired post-operative wound infections [1-4].
If untreated, staphylococcal infections may lead to bacter-
emic seedings of several organs, causing endocarditis,
osteomyelitis and septic arthritis [5,6]. Changes in the
pattern of antimicrobial susceptibility of S. aureus and
other organisms have been reported world wide, espe-
cially in developing countries [7-9], making antimicrobial
agents increasingly less effective in treating bacterial infec-
tions.
Over the past twelve years there have been dramatic
changes in the susceptibility of S. aureus in both hospitals
and community settings in Trinidad [10-12]. The older β-
lactams, penicillin and ampicillin are ineffective against
more than 80 % of isolated strains, and resistance to many
of the non-β-lactam agents such as the tetracyclines, gen-
tamicin, chloramphenicol, erythromycin and clindamy-
cin has gradually increased and reached alarming levels by
the 1990s in many parts of the world [13-15].
Several mechanisms for the methicillin resistance seen in
S. aureus have been elucidated. The most important is the
production of a unique penicillin-binding protein (PBP)
that has a low affinity for β-lactam antibiotics and whose
effects are determined by several structural genes (mec,
mec RI, mec I) [16,17]. Other known mechanisms of
methicillin resistance are the production of the usual
PBPs, but with modified affinities for the β-lactam drugs,
and the hyper production of penicillinase enzyme
[17,18].
Methicillin-resistant  Staphylococcus aureus (MRSA) and
methicillin-sensitive Staphylococcus aureus (MSSA) strains
can easily spread from infected patients to medical staffs,
who often become transient carriers [19]. Because MRSA,
are usually also resistant to other non-β-lactam antibiot-
ics, infections with them are life-threatening in immuno-
compromised patients, often difficult to manage, and
problematic to eradicate. The primary importance is to
decrease the prevalence of MRSA by measures such as
rapid and reliable identification of the organisms along
with their susceptibility patterns to other antibiotics, iso-
lation and treatment of patients and carriers, and strict
adherence to proper hand washing practices by health
care providers.
The purpose of this study was to review and document:
(1) the current prevalence of methicillin resistance among
isolates of S. aureus recovered from hospital and commu-
nity sources and (2), the pattern of antimicrobial suscep-
tibilities of MSSA and MRSA isolates to the commonly
prescribed antibiotics in Trinidad.
Methods
Between January 1, 1999 and December 31, 2004, we
examined strains of S. aureus recovered from various clin-
ical sources from both hospital and community practices
in Trinidad, which had complete susceptibility data. Spec-
imens were derived from patients on the wards and from
those attending outpatients' clinics at the Eric Williams
Medical Sciences Complex (EWMSC). The EWMSC is a
560-bed semi-private medical facility located in the north-
west part of the country. Trinidad is the larger of the twin-
island Republic, Trinidad and Tobago, located about 11
km off the northern coast of Venezuela in South America.
The population of the Republic is about 1.3 million. For
this investigation, no differentiation was between isolates
from inpatients and outpatients, all being classified as
"hospital practice" isolates. S. aureus recovered from
patients attending health centers in the community and
those seen by general practitioners were classified as
"community practice" isolates. For purposes of gathering
infection control surveillance data, other organisms and
duplicates of clinically significant isolates were excluded
from the study.
S. aureus isolates were identified via colonial morphology
on blood agar plates supplemented with 5% sheep blood,
gram stain characteristics, catalase test, tube coagulase
test, mannitol fermentation and DNAse test. Antimicro-
bial susceptibility testing was done on Mueller-Hinton
agar (BBL Microbiology Systems, Cockeysville, Maryland,
USA) using the disc diffusion technique as outlined by the
National Committee for Clinical Laboratory Standards
[20]. The following drugs and concentrations (in brack-
ets) were used to determine the antibiogram of the strains:
ampicillin (10 µg), gentamicin (10 µg), erythromycin (15
µg), tetracycline (30 µg), co-trimoxazole (trimethoprim-
sulfamethoxazole) (1.25/23.75 µg), ciprofloxacin 5 µg),
clindamycin (2 µg) and vancomycin (30 µg). Methicillin-
resistance was tested using a 1 µg oxacillin disc. Zone
diameters were read after incubation at 35°C for a full 24
hr. Strains with zone sizes of < 10 mm for oxacillin was
regarded as methicillin resistant. ATCC S. aureus strains
25923 and 29213 were used as quality control. Statistical
analysis of data was done using X2 test with the Statistical
Package for the Social Sciences, version 9.0.
Results
During the six-year study period, a total of 2430 S. aureus
isolates were recorded. The major sources of S. aureus were
from surgical and burn wounds, pus/abscess, upper respi-
ratory tract and urine which together, accounted for 1805
(74.3%) of all isolates (Table 1). One hundred and nineBMC Infectious Diseases 2006, 6:83 http://www.biomedcentral.com/1471-2334/6/83
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S. aureus strains (4.5%) were from patients with pneumo-
nia, 201 (8.3%) from the blood of patients with sepsis
and 95 (4.0%) from patients with eye infections. The rest
of the isolates were from vaginal, ear, CNS and miscella-
neous infections, each accounting for < 3.0% of the total.
The major source of MRSA was surgical/burn wounds
(60.1%) followed by urine (15.5%), pus/abscess (6.6%)
and blood (6.2%). MSSA was recovered more frequently
from surgical/burn wounds (32.9%), pus/abscess
(17.1%) and the upper respiratory tract (14.3%).
The antimicrobial susceptibility patterns of MSSA isolates
are shown in Table 2. Throughout the study period resist-
ance to the older β-lactam antibiotics increased signifi-
cantly (p < 0.001) in both hospital and community
practices. Resistance patterns of erythromycin, co-trimox-
azole, gentamicin and clindamycin were higher among
hospital isolates when compared to community isolates,
but these differences (except for gentamicin) were not sta-
tistically significant. The reverse situation was seen among
community strains versus hospital strains where resist-
ance rates were considerably higher for ciprofloxacin.
All MRSA isolates were fully sensitive to vancomycin,
while the greatest prevalence of resistance was seen for
erythromycin (86.7%) followed by clindamycin (75.3%),
tetracycline (78.7%) and ciprofloxacin (59.1%). The
remaining isolates had varying degrees of resistance which
accounted for < 45%. Comparison of non-β-lactam resist-
ant MRSA of the current study with a previous study is
shown in Table 3. Resistance rates to erythromycin and
ciprofloxacin were significantly higher when compared to
the 1999 study (p < 0.001). Conversely, there were signif-
icant improvements in susceptibility among MRSA strains
to tetracycline, gentamicin and co-trimoxazole when
compared to the 1999 report [21]. This observation is
encouraging since these drugs are among the cheapest on
the hospital formulary. Interestingly, these drugs are also
infrequently used (except gentamicin) on the wards
(unpublished data). However, these statistical compari-
sons may not have been valid if the number of isolates for
both studies were similar. The ratio of MRSA in the
present study when compared with the previous study was
approximately 10:1. The overall methicillin-resistance
rate was 18.6%. Among hospital strains of MRSA, the rate
of isolation was 20.8%, whereas, the prevalence of resist-
ance among community isolates was 8.1% (Table 4).
Discussion
The present study has shown a steady increase in the prev-
alence rate of MRSA isolation (18.6%) over the previous
study of 9.8%. Similar patterns have been seen worldwide
as evident from the many recorded surveillance studies
[3,4,18]. Despite this observation however; there are con-
siderable differences between individual countries [22].
The highest rates of methicillin resistance among S. aureus
were observed among isolates from the western Pacific
region [15]. In Korea, the rate was 64 % [22], in a major
Table 1: Clinical sources 2430 strains of Staphylococcus aureus 
isolated at the Eric Williams Medical Sciences Complex, 1999 – 
2004
aMRSA bMSSA
Source/Specimen N % N % N %
Wounds (surgical/burns 922 37.9 271 60.1 651 32.9
Pus/abscess 368 15.1 30 6.6 338 17.1
Upper respiratory tract 283 11.6 0 - 283 14.3
Urine 232 9.5 70 15.5 84 4.2
Blood 201 8.3 28 6.2 73 8.7
Lower respiratory tract 109 4.5 25 5.5 84 4.2
Eye discharge 95 4.0 5 1.1 90 4.5
Ear 71 3.0 8 1.8 63 3.2
High vaginal swab 66 2.7 13 2.9 53 2.7
Cerebrospinal fluid 29 1.2 0 - 29 1.5
dMiscellaneous 54 2.2 1 0.2 53 2.7
Total 2430 100 451 100 1979 100
a Methicillin-resistant Staphylococcus aureus; b Methicillin-sensitive 
Staphylococcus aureus; c Peritoneal dialysate, 3; hemodialysate, 6; 
pericardial fluid, 4; pleural fluid, 7; joint fluid, 9; umbilical swab, 25;
Table 2: Percentage of 1979 aMSSA strains resistant to various antimicrobial agents at the Eric Williams Medical Sciences Complex, 
1999 – 2004
Antimicrobial Hospital Practice (n = 1375) Community Practice (n = 604) Significance (P-value)
Ampicillin 1356 (98.6) 412 (68.2) < 0.001
Tetracycline 587(42.7) 444 (73.5) < 0.001
Erythromycin 198 (14.4) 37 (6.1) NS
Clindamycin 144 (10.5) 50 (8.3) NS
1Co-trimoxazole 140 (10.2) 26 (4.3) NS
Gentamicin 268 (19.5) 7 (1.2) < 0.001
Ciprofloxacin 28 (2.0) 45 (7.5) NS
Oxacillin 0 0 __
Vancomycin 0 0 __
aMethicillin-sensitive Staphylococcus aureus; 1Trimethoprim-sulfamethoxazole.BMC Infectious Diseases 2006, 6:83 http://www.biomedcentral.com/1471-2334/6/83
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Taiwanese hospital resistance rate was found to be about
77% [23]. In North America [4,24,25], the Middle East
[7,9,13,26], India [27] and the Canary Islands [28] rates
of 38 – 50%, 33–40%, 18 – 43% and 25% respectively,
have been reported. MRSA rates from the Caribbean are
scanty, but data from a previous report [21], Jamaica [29],
Cuba [30] and a French territory island [31] have shown
rates of isolation to be < 10%. From South America [4,32-
34] and Europe [18,35,36], rates of 10 – 66% and 25 –
58% respectively, have been seen. These different rates
among MRSAs from different countries maybe attributed
to variations in patient populations, the biological charac-
teristics of the S. aureus strains, and/or infection control
practices.
The current study showed that the epidemiology of MRSA
at this institution has changed. Although MRSA remains
largely a nosocomial pathogen, 8.1% of isolates were
community-acquired. Several factors maybe at play in the
increasing prevalence of community-acquired MRSA. One
reason for this increase maybe lateral dissemination of
MRSA from hospital to the community from discharged
patients diagnosed with MRSA, and the discontinuation
of therapy because of the high cost of prescribed drugs at
local pharmacies. These strains of MRSA are frequently
multi-resistant. Two reports from Australia suggests that
while lateral dissemination from hospital to community
may be a major factor, strains of MRSA isolated from peo-
ple in a remote western area of the country shows no sim-
ilarity to hospital-derived strains. These people have had
little or no contact with urban cities, health care facilities
or health care providers, and these MRSA are generally
non-multi-resistant [37,38]. The authors used multi-locus
sequence typing and protein A gene typing, as well as sus-
ceptibility profiles in evaluating relatedness of the com-
munity-acquired MRSA strains. Although molecular
techniques were not applied in this study, the multi-resist-
ance as seen among community strains would suggest that
these strains may have originated from the hospital.
The methicillin resistance rate of 20.8% as seen among
hospital isolates was considerable higher than the 1999
rate of 12.5%. Community MRSA prevalence remained
relatively stable over the past 6 years (4.1% in 1999 to
8.1% in 2004), but this was not statistically significant.
These increases as seen in the study are certainly a cause
for concern in Trinidad and may very well represent a
trend in the changing epidemiology of MRSA in the
2000s. Although a protocol exists for the management of
infected patients and colonized health care providers
(HCPs), it is rarely implemented. The protocol requires
the physical separation of infected patients and their
HCPs from uninfected patients, therapy for eradicating
MRSA, stringent environmental disinfection of areas har-
boring MRSA and the application of barrier isolation pre-
caution measures, including strictly enforced hand
hygiene to interrupt spread patterns. A previous report
from this country revealed that proper hand washing prac-
tices and sanitation techniques of HCPs at all levels of
service were not strictly adhered to [39]. The situation is
further complicated by the fact that HCPs frequently com-
plain of overcrowded wards, scarce material resources and
overworked personnel.
Conclusion
The study has shown that the prevalence of MRSA infec-
tions has increased over the years. The principal source
may have been the hands of HCPs during wound dressing
exercises. Infection control measures such as proper hand
hygiene and surveillance cultures may help in arresting
the spread of MRSA in the hospital setting. An antibiotic
policy and the monitoring of susceptibility patterns of
MRSA may also help in decreasing the prevalence of
MRSA and antibiotic resistance.
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Table 3: Comparison of the current resistance patterns of 
aMRSA with a previous study at the Eric Williams Medical 
Sciences Complex
Antimicrobial Current Study 
1999 – 2004 
(n = 451)
Previous Study 
1997 – 1998 
(n = 44)
P-value
Erythromycin 86.7 68.2 < 0.001
Tetracycline 78.7 93.2 < 0.001
Gentamicin 44.7 61.4 < 0.001
1Co-trimoxazole 13.3 45.4 < 0.001
Ciprofloxacin 59.1 20.5 < 0.001
Chloramphenicol 17.3 _ _
Clindamycin 75.3 - -
aMethicillin-resistant Staphylococcus aureus, 1Trimethoprim-
sulfamethoxazole.
Table 4: Distribution of 2430 Staphylococcus aureus strains 
isolated from hospital practice and community practice at the 
Eric Williams Medical Sciences Complex, according to 
methicillin-resistance, 1999 – 2004.
Methicillin No. of hospital 
isolates (%)
No. of community 
isolates (%)
Total (%)
Sensitive 1581 (79.2) 398 (91.9) 1979 (81.4)
Resistant 416 (20.8) 35 (8.1) 451 (18.6)
Total 1997 (100) 433 ((100) 2430 (100)
Hospital MRSA: 1998 versus 2004, X2 = 2.28; P = NS; Community 
bMRSA: 1998 versus 2004, X2 = 2.48; P = NS.BMC Infectious Diseases 2006, 6:83 http://www.biomedcentral.com/1471-2334/6/83
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